VSIR (KVA-12.1 Biosimilar) Recombinant Monoclonal Antibody

Code: CSB-RA884484MB2HU
Size:
100ug
100ug500ug1mg5mg10mg50mg100mg200mg
US$199
Quantity:
Species Reactivity: Human
For inquiries on large quantities or another requirements
Send an Inquiry
Start an on-line Chat
Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details

Uniprot NO.
Alternative Names
KVA12.1 research-grade biosimilar; KVA 12.1 research-grade biosimilar; KVA-12.1 research-grade biosimilar; KVA12123 research-grade biosimilar; TBS-2025 research-grade biosimilar ;VSIR antibody; C10orf54 antibody; SISP1 antibody; VISTA antibody; PP2135 antibody; UNQ730/PRO1412 antibody; V-type immunoglobulin domain-containing suppressor of T-cell activation antibody; Platelet receptor Gi24 antibody; Stress-induced secreted protein-1 antibody; Sisp-1 antibody; V-set domain-containing immunoregulatory receptor antibody; V-set immunoregulatory receptor antibody
Species Reactivity
Human
Immunogen
Recombinant Human VSIR protein
Conjugate
Non-conjugated
Clonality
Monoclonal
Buffer
0.01M PBS,pH7.4
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Lead Time
3-4 weeks
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Concentration
It differs from different batches. Please contact us to confirm it.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
Datasheet & COA
Description

This recombinant monoclonal antibody is a research-grade biosimilar of KVA-12.1, targeting VSIR (also known as VISTA, V-domain Ig suppressor of T cell activation)—a type I transmembrane immunoregulatory receptor that functions as an immune checkpoint. VISTA is prominently associated with myeloid-lineage cells (including MDSCs, monocytes/macrophages) and is also described on T-cell compartments (notably including naïve T cells), where it helps maintain immune quiescence and suppress excessive activation. In tumor settings, VISTA-linked signaling is frequently discussed as a contributor to myeloid-mediated immunosuppression and an axis of checkpoint resistance biology within the tumor microenvironment.

KVA-12.1 is described as a fully human anti-VISTA monoclonal antibody being developed for immuno-oncology, including evaluation in monotherapy and combination with anti–PD-1 strategies. This biosimilar provides the antibody component alone, enabling researchers to investigate VISTA checkpoint biology—such as VISTA-associated suppression of T-cell effector function, regulation of MDSC-mediated inhibition, and target engagement effects on myeloid/T-cell crosstalk—independent of other therapeutic agents. It also supports assay development around VISTA–ligand pathway modulation (e.g., interactions reported with partners like PSGL-1 or VSIG3) and exploratory studies evaluating VISTA/VSIR as a biomarker or mechanistic driver in immunosuppressive microenvironments.

Customer Reviews and Q&A

 Customer Reviews

Target Background

Function(From Uniprot)
Immunoregulatory receptor which inhibits the T-cell response. May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling. May stimulate MMP14-mediated MMP2 activation.
Gene References into Functions
  1. Data indicate that VISTA is predominantly expressed and up-regulated in the high-density infiltrated immune cells but minimal in pancreatic cancerous cells. PMID:29771768
  2. High VISTA expression is associated with colorectal carcinoma. PMID:30128738
  3. VISTA expression supports immune-complex inflammation in collagen antibody-induced arthritis and VISTA is expressed in human synovium PMID:29216931
  4. This study is the first to describe the expression of VISTA-expressing lymphocytes in melanoma samples and in the context of acquired resistance to immune checkpoint inhibitors PMID:28776578
  5. Taken together, the results indicated that the VISTA high and CD8 low group, as an immunosuppressive subgroup, might be associated with a poor prognosis in primary OSCC. These findings indicated that VISTA might be a potential immunotherapeutic target in OSCC treatment. PMID:28236118
  6. this review describes the functions of VISTA in the context of cancer immunotherapy PMID:28258694
  7. overexpression of the newly described co-stimulatory molecule, PD1 homologue (PD-1H) in human monocyte/macrophages is sufficient to induce spontaneous secretion of multiple cytokines. PMID:25279955
  8. p53-induced expression of DD1alpha prevents persistence of cell corpses and ensures efficient generation of precise immune responses in mice. PMID:26228159
  9. Results suggest that GI24 contributes to tumor-invasive growth in the collagen matrix by augmenting cell surface MT1-MMP. PMID:20666777

Show More

Hide All

Subcellular Location
Cell membrane; Single-pass type I membrane protein.
Tissue Specificity
Expressed in spleen. Detected on a number of myeloid cells including CD11b monocytes, CD66b+ neutrophils, at low levels on CD4+ and CD8+ T-cells, and in a subset of NK cells. Not detected on B cells (at protein level). Expressed at high levels in placenta
Database Links

HGNC: 30085

UNIGENE: Hs.47382

KEGG: hsa:64115

STRING: 9606.ENSP00000378409

OMIM: 615608

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
No. 269, Shendun 5th Road, Donghu Hi-Tech Development Area, Hubei Province, 430206, P.R.China
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Select 0 Products